Recommanded Product: 5,5′-Dimethyl-2,2′-bipyridine. Aromatic heterocyclic compounds can also be classified according to the number of heteroatoms contained in the heterocycle: single heteroatom, two heteroatoms, three heteroatoms and four heteroatoms. Compound: 5,5′-Dimethyl-2,2′-bipyridine, is researched, Molecular C12H12N2, CAS is 1762-34-1, about Synthesis, crystal structures and biological activity of palladium(II) complexes with 1-methyl-1H-1,2,3,4-tetrazole-5-thiol and substituted 2,2′-bipyridines. Author is Rashidipour, Arezoo; Alizadeh, Robabeh; Sadeghi Mohammadi, Sanam; Tohidlou, Mohammad; Amani, Vahid; Seyfi, Sara.
Reaction of PdCl2 with 1-methyl-1H-1,2,3,4-tetrazole-5-thiol (Hmtzt) in the presence of 5,5′-dimethyl-2,2′-bipyridine (5,5′-dmbipy) and 4,4′-dimethyl-2,2′-bipyridine ligands (4,4′-dmbipy) afforded two new Pd(II) complexes, [Pd(5,5′-dmbipy)(mtzt)2] (1) and [Pd(4,4′-dmbipy)(mtzt)2] (2), resp. The two complexes were thoroughly characterized by elemental anal., UV-vis, 1H NMR, IR, luminescence spectroscopy as well as single-crystal X-ray diffraction. Single-crystal X-ray diffraction revealed that central Pd(II) ions in and are tetra-coordinated, presenting distorted and slightly distorted square planar geometry around Pd atom for and , resp. The luminescence properties of free ligands and complexes 1 and 2, in solution, were investigated. The biol. evaluation of the Pd(II) complexes showed that they exhibited anticancer activities in a dose-dependent manner against human breast cancer cell lines. Also, their in vitro interaction with DNA were analyzed through spectrophotometric, spectrofluorometric, and gel-electrophoresis which shows the intercalation mode of binding. In conclusion, these palladium complexes represent novel anticancer drug mols. for further study.
Compounds in my other articles are similar to this one(5,5′-Dimethyl-2,2′-bipyridine)Recommanded Product: 5,5′-Dimethyl-2,2′-bipyridine, you can compare them to see their pros and cons in some ways,such as convenient, effective and so on.